Trevi Therapeutics, Inc (TRVI) insider trading
Every open-market stock purchase and sale by Trevi Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Michael Thomas Heffernan (Insider) sold $594K in the last 90 days.
- Last insider buy: Ali Behbahani (10% owner), $5.7M, 4 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $594K (1 sale). Last close $12.77 on Oct 21, 2026.
Recent TRVI insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | Michael Thomas Heffernan (Insider) | Sold | $316K |
| Sep 15, 2026 | Michael Thomas Heffernan (Insider) | Sold | $276K |
| Sep 15, 2026 | Michael Thomas Heffernan (Insider) | Bought (not open market) | $70.1K |
| Sep 15, 2026 | Michael Thomas Heffernan (Insider) | Bought (not open market) | $56K |
| Sep 15, 2026 | Michael Thomas Heffernan (Insider) | Sold | $1.6K |
| Sep 15, 2026 | Michael Thomas Heffernan (Insider) | Bought (not open market) | — |
| Sep 15, 2026 | Michael Thomas Heffernan (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Dominick Colangelo (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Michael Thomas Heffernan (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Edward T Mathers (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | David P Meeker (Insider) | Bought (not open market) | — |
| Jun 3, 2026 | Anne Vanlent (Insider) | Bought (not open market) | — |
| Feb 19, 2026 | Jennifer L Good (CEO) | Bought (not open market) | — |
| Feb 19, 2026 | James V Cassella (C-suite exec) | Bought (not open market) | — |
| Feb 19, 2026 | Christopher Galletta (Insider) | Bought (not open market) | — |
| Feb 19, 2026 | Thomas Sciascia (C-suite exec) | Bought (not open market) | — |
| Feb 19, 2026 | Farrell Simon (C-suite exec) | Bought (not open market) | — |
| Jan 8, 2026 | David C Hastings (CFO) | Bought (not open market) | — |
| Dec 2, 2025 | Christopher Galletta (Insider) | Bought (not open market) | — |
Who's trading TRVI
- Michael Thomas Heffernan, Insider: sold $594K (3 sales), last Sep 15, 2026
- Dominick Colangelo, Insider: other filings, last Jun 3, 2026
- Edward T Mathers, Insider: other filings, last Jun 3, 2026
- David P Meeker, Insider: other filings, last Jun 3, 2026
- Anne Vanlent, Insider: other filings, last Jun 3, 2026
- James V Cassella, C-suite exec: other filings, last Feb 19, 2026
- Jennifer L Good, CEO: other filings, last Feb 19, 2026
- Christopher Galletta, Insider: other filings, last Feb 19, 2026
- Thomas Sciascia, C-suite exec: other filings, last Feb 19, 2026
- Farrell Simon, C-suite exec: other filings, last Feb 19, 2026
- David C Hastings, CFO: other filings, last Jan 8, 2026
Get free alerts when an insider at Trevi Therapeutics, Inc files a new trade →